Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.

Cicconi P. et al, (2019), Clin Infect Dis

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV).

McNaughton AL. et al, (2019), Sci Rep, 9

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.

Green CA. et al, (2019), J Infect, 78, 382 - 392

Single-cell transcriptome analysis of CD8 + T-cell memory inflation.

Highton AJ. et al, (2019), Wellcome Open Res, 4

Humoral and cellular immunity to RSV in infants, children and adults.

Green CA. et al, (2018), Vaccine, 36, 6183 - 6190

Adenoviral vaccine induction of CD8+ T cell memory inflation: Impact of co-infection and infection order.

Lee LN. et al, (2017), PLoS Pathog, 13

MAIT cells are activated during human viral infections.

van Wilgenburg B. et al, (2016), Nat Commun, 7

Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man.

Bolinger B. et al, (2015), Cell Rep, 13, 1578 - 1588

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults.

Green CA. et al, (2015), BMJ Open, 5

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.

Green CA. et al, (2015), Sci Transl Med, 7

CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner.

Ussher JE. et al, (2014), Eur J Immunol, 44, 195 - 203

A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector.

Bolinger B. et al, (2013), J Immunol, 190, 4162 - 4174

Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.

Zhang Y. et al, (2013), PLoS Pathog, 9

CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis.

Lee LN. et al, (2011), Infect Immun, 79, 3328 - 3337

Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects.

Wallace DL. et al, (2011), Immunology, 132, 27 - 38

Simultaneous immunization against tuberculosis.

Tchilian EZ. et al, (2011), PLoS One, 6

Accelerated CD4(+) T cell turnover in HIV infection preferentially drives proliferation of CCR5(+) cells regardless of HIV viral co-receptor tropism

Zhang Y. et al, (2010), IMMUNOLOGY, 131, 126 - 127

Measurement of proliferation and disappearance of rapid turnover cell populations in human studies using deuterium-labeled glucose.

Macallan DC. et al, (2009), Nat Protoc, 4, 1313 - 1327

In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection.

Zhang Y. et al, (2007), Immunology, 121, 258 - 265

In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.

Asquith B. et al, (2007), Proc Natl Acad Sci U S A, 104, 8035 - 8040

Load More